new treatment algorithm to select drugs for Parkinson's disease

Experts are using a new treatment algorithm to select drugs for Parkinson's disease.

It emphasizes dopamine agonists for INITIAL therapy in most patients who have disabling symptoms.

Dopamine agonists are less likely to cause the motor problems seen with levodopa...and they may have neuroprotective effects.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote